Physician profile
William Michael Stevens
NPI 1528186434
$268.42
in general payments reported to CMS, 2019-2025
10 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.01 · 2021: $14.36 · 2022: $13.92 · 2023: $17.51 · 2024: $55.93 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $68.19 | 2025 | |
| Abbvie INC. | $37.25 | 2019 | |
| Avion Pharmaceuticals | $28.28 | 2021-2022 | |
| Organon LLC | $23.28 | 2024 | |
| Merck Sharp & Dohme LLC | $22.76 | 2019 | |
| Medtronic, INC. | $20.13 | 2025 | Ligasure |
| Ethicon US, LLC | $18.37 | 2025 | Harmonic, Enseal |
| Dexcom, INC. | $17.51 | 2023 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $16.65 | 2024 | Myfembree |
| Pfizer INC. | $16.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.